published on 08/19/2026 at 17:49

SS Innovations International (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

Austin, Texas, August 19th, 2026, FinanceWire

SS Innovations, developer of innovative surgical robotic technologies, reported record second-quarter revenue of $13.9 million, up 39.4% year over year.
First-half revenue reached $25.0 million, a 65.6% increase from the same period in 2025.
The company’s SSi Mantra installations rose 30.4% to 30 systems during the quarter.
The installed base reached 224 SSi Mantra systems across 12 countries, with 12,272 cumulative surgeries performed.
U.S. and European regulatory milestones could become important catalysts, with the company targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026.
The company’s telesurgery achievements are extending the clinical profile of SSi Mantra, while system installations remain the primary commercial growth driver.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, delivered another quarter of rapid top-line growth as demand for its SSi Mantra surgical robotic system continued to expand. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million a year earlier. Gross profit increased 20.0% to $7.1 million, although gross margin declined to 50.9% from 59.1% in the year-earlier quarter (https://nnw.fm/zxrT1).

The stronger comparison comes over the first six months of the year. Revenue reached $25.0 million, up 65.6% from $15.1 million in the first half of 2025. Gross profit increased 77.5% to $12.4 million, while first-half gross margin improved to…

SS Innovations International (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

SS Innovations International (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform